BloomMD GLP-1 Natural Booster
A dihydroberberine product at $69 a bottle marketed explicitly as a natural GLP-1 alternative and as something to take alongside Ozempic, Wegovy or tirzepatide, including while tapering off them. It does advise consulting a healthcare provider if you are on a prescription GLP-1, which is the right caveat — and a necessary one, because combining glucose-lowering agents is where the actual risk in this product sits.
Last reviewed · researched from the manufacturer’s published pages by Tom
What’s in it
Amounts are shown only where the manufacturer publishes them. Anything without a figure is undisclosed — and for an active ingredient, an undisclosed dose is the central problem with this category.
- Dihydroberberine (DHB)amount not published
A metabolite of berberine; the company states up to five times greater bioavailability than standard berberine. The per-serving amount was not published on the page we captured
How the manufacturer says it works
BloomMD describes dihydroberberine as “Nature's GLP-1”, stating it enhances GLP-1 secretion and improves insulin sensitivity, activates AMPK pathways, and may complement prescription GLP-1 therapy or serve as a natural alternative. It advises consulting a healthcare provider if you are taking prescription GLP-1 medications.
What the evidence actually supports
Dihydroberberine is a genuine berberine metabolite and the bioavailability point is real: standard berberine is poorly absorbed, which is the main limitation of the ingredient, and DHB was developed to address it. Berberine itself has the strongest research base of anything in this category, with meta-analyses generally reporting modest improvements in fasting glucose, HbA1c and lipid markers.
Where that evidence stops
Berberine and dihydroberberine act principally through AMP-activated protein kinase, not the GLP-1 receptor — calling it “Nature's GLP-1” describes marketing rather than mechanism. Effects on body weight specifically are much smaller and less consistent than effects on glucose markers, and nothing in the berberine literature approaches the weight loss reported in the GLP-1 drug trials. The per-serving dose is not published, so it cannot be compared with the doses used in studies. Most importantly, berberine inhibits CYP3A4 and other drug-metabolising enzymes and can raise blood levels of common prescription medications; taking it alongside a GLP-1 medication also stacks two glucose-lowering agents. The page's advice to consult a provider is the correct one and should not be treated as optional.
Strengths and problems
Strengths
- Dihydroberberine addresses the real bioavailability limitation of standard berberine
- Explicitly tells prescription GLP-1 users to consult a healthcare provider
- Single named active rather than a proprietary blend
- Published multi-bottle pricing
Problems
- Marketed as “Nature's GLP-1” when the mechanism is AMPK, not the GLP-1 receptor
- No per-serving amount published, so the dose cannot be compared with the research
- Suggested for use during tapering off a prescription, which is a clinical decision rather than a shopping one
- At $69 a bottle it is expensive for a single-ingredient dihydroberberine product
- Third-party testing, allergens and refund terms were not published on the page we captured
What the manufacturer publishes
Publishes 3 of 8 standard terms.
- Intended use
- Sold as a dietary supplement for appetite regulation and blood sugar support, not as a treatment for any condition.
- Directions
- Take as directed, per the product description.
- Warnings
- States you should consult your healthcare provider if you are on prescription GLP-1 medications.
- Allergens
- Not publicly disclosed on the pages we captured.
- Third-party testing
- Not publicly disclosed on the pages we captured.
- Pricing
- $69 for a single bottle, $119 for a double pack and $169 for a triple pack at capture.
- Subscription
- Not publicly disclosed on the pages we captured.
- Refunds
- Not publicly disclosed on the pages we captured.
- Shipping
- Not publicly disclosed on the pages we captured.
May suit
Someone specifically interested in dihydroberberine for glucose markers who has cleared it with a pharmacist, and who is comparing it on price against labelled alternatives.
Do not use if
- You take any prescription medication and have not checked interactions with a pharmacist — berberine inhibits CYP3A4
- You are on a prescription GLP-1 and have not discussed adding this with the prescriber
- You take glucose-lowering medication — additive hypoglycaemia risk
- You are pregnant or breastfeeding
Frequently asked
Is dihydroberberine “Nature's GLP-1”?
No. Dihydroberberine acts mainly on AMPK, an energy-sensing enzyme, not on the GLP-1 receptor that semaglutide and tirzepatide target. It has real research behind it for glucose and lipid markers, and that is a claim worth taking seriously. The GLP-1 label is a marketing frame, and the two claims should not be confused.
Can I take it while coming off a GLP-1?
That is a question for the clinician managing your treatment, not for a product page. Weight regain after stopping a GLP-1 is well documented, and it is understandable to want something to bridge the gap — but berberine interacts with a long list of prescription medications through CYP3A4, and it lowers glucose, which matters if you are still tapering an agent that does the same. BloomMD's own advice is to consult your provider. Follow it.
Sources
Captured . Manufacturer pages change — check the current version before relying on anything.